Literature DB >> 12911493

Mizoribine oral pulse therapy for a patient with severe lupus nephritis.

Hiroshi Tanaka1, Koichi Suzuki, Tohru Nakahata, Tomohiko Sato, Etsuro Ito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12911493     DOI： 10.1046/j.1442-200x.2003.01749.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN： 1328-8067            Impact factor:   1.524


× No keyword cloud information.
  3 in total

1.  Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.

Authors:  Hiroshi Tanaka; Koji Tsugawa; Koichi Suzuki; Tohru Nakahata; Etsuro Ito
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

2.  Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome.

Authors:  Yukihiko Kawasaki; Junzo Suzuki; Ai Takahashi; Masato Isome; Ruriko Nozawa; Hitoshi Suzuki
Journal:  Pediatr Nephrol       Date:  2004-10-21       Impact factor: 3.714

3.  Long-term post-marketing surveillance of mizoribine for the treatment of lupus nephritis: Safety and efficacy during a 3-year follow-up.

Authors:  Nobuyuki Yagi; Kenya Okada; Yohei Sudo; Hiromichi Itoh; Hisao Yoshida; Tatsuhiko Kuroda
Journal:  SAGE Open Med       Date:  2014-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.